Chikungunya virus specific detection antigen and application thereof
A virus and auxiliary detection technology, applied in the direction of applications, viruses, virus peptides, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0052] Example 1. Preparation of Chikungunya Virus Specific Detection Antigen
[0053] 1. Chikungunya virus recombinant protein sequence information
[0054] According to the structural characteristics of the E protein of Chikungunya virus, E1 and E2 were divided into different antigen fragments for segmented expression, and specific amplification primers were designed. The fragment length, primer sequence and restriction site information are shown in Table 1.
[0055] Table 1 Fragment length, primer sequence and restriction site information of 3 different antigen fragments
[0056]
[0057] Note: In the table, the underlined part in the upstream primer is the recognition sequence of the restriction site BamHI; the underlined part in the downstream primer is the recognition sequence of the restriction site HindIII.
[0058] 2. Construction of recombinant expression vector
[0059] Use Invitrogen's RNA extraction kit to extract the RNA of Chikungunya virus S27 strain, and use TaKaRa's on...
Embodiment 2
[0075] Example 2. Effect detection of specific detection antigen of Chikungunya virus
[0076] Two different Chikungunya virus E protein fragments (E2-1 and E1-1) prepared in Example 1 were used as detection antigens, and two clinical Japanese encephalitis patients (JEV) infected serum and two forests were collected. Encephalitis (TBEV) patient infection serum samples, 2 dengue (DV) patient infection serum samples, 5 normal human serum samples, 12 chikungunya virus (CHIK) infection serum (the above sera are all clinically confirmed patient sera , Normal human serum was from PLA 307 Hospital, Japanese encephalitis patient serum and forest encephalitis human serum were from Xinjiang Military Region CDC, chikungunya patient serum and dengue patient serum were from Guangzhou Eighth People’s Hospital), and ELISA was used. To evaluate the detection specificity and sensitivity of each recombinant antigen. The steps are as follows:
[0077] (1) The two Chikungunya virus antigens E2-1 and...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com